InCellDx Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

InCellDx General Information

Description

Developer of precision diagnostic technology intended to diagnose and treat chronic inflammatory diseases through machine learning and AI-based precision diagnostics. The company offers precision diagnostics, diagnostic testing, pharmaceutical treatments, health data platforms, telemedicine services, and biometric monitoring, enabling patients to undergo diagnosis, treatment, and management of chronic inflammatory diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 30920 Huntwood Avenue
  • Hayward, CA 94544
  • United States
+1 (650)
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Corporate Office
  • 30920 Huntwood Avenue
  • Hayward, CA 94544
  • United States
+1 (650)

InCellDx Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InCellDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Feb-2025 Completed Generating Revenue
5. Later Stage VC 23-Jul-2024 Completed Generating Revenue
4. Secondary Transaction - Private Completed Generating Revenue
3. Later Stage VC (Series A1) 08-Jan-2023 Completed Generating Revenue
2. Early Stage VC (Series A1) 10-May-2012 $6M $9M Completed Startup
1. Early Stage VC (Series A) 15-Jun-2010 $3M $3M Completed Startup
To view InCellDx’s complete valuation and funding history, request access »

InCellDx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1
Series A
To view InCellDx’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

InCellDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of precision diagnostic technology intended to diagnose and treat chronic inflammatory diseases through machin
Biotechnology
Hayward, CA
22 As of 2026

Boston, MA
 

Nehren, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InCellDx Competitors (43)

One of InCellDx’s 43 competitors is Foundation Medicine, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Foundation Medicine Formerly VC-backed Boston, MA
Hain Lifescience Corporate Backed or Acquired Nehren, Germany
Illumina Formerly VC-backed San Diego, CA
TopoGen Corporation Buena Vista, CO
AusDiagnostics Formerly PE-Backed Mascot, Australia
You’re viewing 5 of 43 competitors. Get the full list »

InCellDx Patents

InCellDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4754535-A1 Methods of assigning a covid pathological type and compositions for practicing the same, and methods of treating a subject for chronic covid-19 Pending 01-Aug-2023
WO-2025029797-A1 Methods of assigning a covid pathological type and compositions for practicing the same, and methods of treating a subject for chronic covid-19 Inactive 01-Aug-2023
WO-2023192361-A1 Methods of treating a subject for fibromyalgia and compositions for use in the same Inactive 31-Mar-2022
EP-4499098-A1 Methods of treating a subject for myalgic encephalomyelitis/chronic fatigue syndrome (me/cfs) and compositions for use in the same Pending 31-Mar-2022
EP-4499098-A4 Methods of treating a subject for myalgic encephalomyelitis/chronic fatigue syndrome (me/cfs) and compositions for use in the same Pending 31-Mar-2022 A61K31/46
To view InCellDx’s complete patent history, request access »

InCellDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InCellDx Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boomerang Catapult Venture Capital Minority
Stony Lonesome Group Venture Capital Minority
To view InCellDx’s complete investors history, request access »

InCellDx FAQs

  • When was InCellDx founded?

    InCellDx was founded in 2009.

  • Where is InCellDx headquartered?

    InCellDx is headquartered in Hayward, CA.

  • What is the size of InCellDx?

    InCellDx has 22 total employees.

  • What industry is InCellDx in?

    InCellDx’s primary industry is Biotechnology.

  • Is InCellDx a private or public company?

    InCellDx is a Private company.

  • What is InCellDx’s current revenue?

    The current revenue for InCellDx is .

  • How much funding has InCellDx raised over time?

    InCellDx has raised $20M.

  • Who are InCellDx’s investors?

    Boomerang Catapult and Stony Lonesome Group have invested in InCellDx.

  • Who are InCellDx’s competitors?

    Foundation Medicine, Hain Lifescience, Illumina, TopoGen, and AusDiagnostics are some of the 43 competitors of InCellDx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process